Innovent Biologics Market Cap

Innovent Biologics has a market cap or net worth of €17.41 billion as of December 5, 2025. Its market cap has increased by 132.14% in one year.

Market Cap

17.41B

Enterprise Value

16.66B

Revenue

1.36B

Ranking

n/a

PE Ratio

129.36

Stock Price

€9.95

Market Cap Chart

Since October 31, 2018, Innovent Biologics's market cap has increased from 2.09B to 17.41B, an increase of 733.57%. That is a compound annual growth rate of 34.80%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	17.41B	133.52%
Dec 31, 2024	7.46B	-6.93%
Dec 29, 2023	8.01B	29.87%
Dec 30, 2022	6.17B	-22.46%
Dec 31, 2021	7.96B	-34.45%
Dec 31, 2020	12.14B	216.45%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SAP SE	248.93B
Siemens Aktiengesellschaft	181.89B
Allianz SE	139.43B
Deutsche Telekom AG	131.24B
Siemens Energy AG	99.98B
Rheinmetall AG	70.18B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München	68.26B
Deutsche Bank Aktiengesellschaft	59.33B

Market Cap Rankings